AI-Powered Chest X-Ray Analysis for Incidental ILD Detection: Real-World Performance Data from 1,293-Patient Korean Cohort — Implications for Radiological Practice
247 Health News Editorial
·24 July 2026
·5 min read
·clinical-trialsA completed 1,293-patient Korean observational study has evaluated the real-world positive predictive value of VUNO Med®-Chest X-ray™ in detecting incidental interstitial lung disease on routine chest radiographs. The findings have significant implications for respiratory and radiology practice globally, including in Australia where TGA regulation of AI-based diagnostic software is evolving rapidly.
Originally reported by ClinicalTrials.gov
References
- 1.Chung-Ang University Hospital. (2024). Evaluating the real-world performance of artificial intelligence (AI)-based detection for interstitial lung disease in chest X-ray images (NCT07686562). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07686562
- 2.Jegal, Y., Kim, D. S., Shim, T. S., Lim, C. M., Do Lee, S., Koh, Y., Kim, W. S., Kim, W. D., Lee, J. S., Travis, W. D., & Oh, Y. M. (2005). Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. American Journal of Respiratory and Critical Care Medicine, 171(6), 639–644. https://doi.org/10.1164/rccm.200403-331OC
- 3.Lamas, D. J., Kawut, S. M., Bagiella, E., Philip, N., Arcasoy, S. M., & Lederer, D. J. (2011). Delayed access and survival in idiopathic pulmonary fibrosis: A cohort study. American Journal of Respiratory and Critical Care Medicine, 184(7), 842–847. https://doi.org/10.1164/rccm.201103-0493OC
- 4.Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., Flaherty, K. R., Wells, A., Martinez, F. J., Azuma, A., Bice, T. J., Bouros, D., Brown, K. K., Collard, H. R., Duggal, A., … Wilson, K. C. (2018). Diagnosis of idiopathic pulmonary fibrosis: An official ATS/ERS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 198(5), e44–e68. https://doi.org/10.1164/rccm.201807-1255ST
- 5.Therapeutic Goods Administration. (2023). Australian public assessment report for nintedanib. Australian Government Department of Health. https://www.tga.gov.au
- 6.Walsh, S. L. F., Calandriello, L., Silva, M., & Sverzellati, N. (2018). Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: A case-cohort study. The Lancet Respiratory Medicine, 6(11), 837–845. https://doi.org/10.1016/S2213-2600(18)30286-8
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service